Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Inhibitex Inc. (INHX), Atlanta, Ga. Business: Infectious Appointed: Erik De Clercq, professor
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury